Nivolumab 360 / Carboplatin 5 / Paclitaxel 175, nichtkleinzelliges Lungenkarzinom, neoadjuvant, Zyklus 1-4 (PID2642 V1.0)
Carboplatin (ATC L01XA02)
- FachInfo: Carboplatin (Carbomedac® 10 mg/ml, i.v.)
- PC Compound: Carboplatin
- PC Substance: Carboplatin
- Rote Liste: Carboplatin
- URL: Carboplatin Dosisreduktion Nierenfunktion
Cimetidin (ATC A02BA01)
- FachInfo: Cimetidin (H2Blocker-ratiopharm® 200 mg/2 ml, Injektionslösung)
- PC Compound: Cimetidine
Dexamethason (ATC H02AB02)
- FachInfo: Dexamethason Dexa-ratiopharm 4 mg/8 mg Injektionslösung
- FachInfo: Dexamethason (Fortecortin, Merck, 0,5 mg, 2mg, 4mg, 8mg, p.o.)
- PC Compound: Dexamethasone
- PC Substance: Dexamethason
Dimetinden (ATC R06AB03)
- FachInfo: Dimentinden (Fenistil®, NOVARTIS, Dimetindenmaleat 1mg/ml, i.v.)
- PC Compound: Dimetinden
- PC Substance: Dimetinden
- PC Substance: Dimetindenmaleat
Fosaprepitant (ATC A04AD12)
- EMA EPAR: Fosaprepitant (ivemend)
- FachInfo: Fosaprepitant (IVEMEND®, MSD, 150 mg, i.v.)
- PC Compound: Fosaprepitant
- PC Substance: Fosaprepitant
Granisetron (ATC A04AA02)
- EMA EPAR: Granisetron (Sancuso, 3.1 mg/24 hours transdermal
- EMA URL: Kytril, granisetron
- FachInfo: Granisetron (Granisetron Kabi, 1 mg/ml, i.v.)
- FachInfo: SANCUSO® 3,1 mg/24 Stunden transdermales Pflaster
- PC Compound: Granisetron
- PC Substance: Granisetron
Nivolumab (ATC L01FF01)
- EMA EPAR: Nivolumab (Opdivo)
- FachInfo: Nivolumab (Nivolumab BMS, Bristol-Meyers Squibb, 10mg/ml, i.v.)
- FDA: Nivolumab (Opdivo)
- PC Substance: Nivolumab
- PC Substance: Nivolumab
Paclitaxel (ATC L01CD01)
- EMA EPAR: Paclitaxel (Pazenir)
- FachInfo: Paclitaxel (Paclitaxel onkovis, 6 mg/ml, i.v.)
- PC Compound: Nab-paclitaxel
- PC Substance: Paclitaxel
- PMID: One-hour paclitaxel infusions: review of safety and efficacy.
- PMID: Paclitaxel (Taxol): phase I/II trial comparing 1-hour infusion schedules.